title: The changing healthcare market: outlook for the future of cardiovascular disease treatment--Part 2.
abstract: This paper, the second in a series of 2, reviews major developments and trends in the current healthcare arena that will affect cardiovascular disease (CVD) treatment over the next 10 years. The paper also discusses the implications and future outlook for cardiovascular services in a managed care environment.
authors.affiliation: Rollins School of Public Health at Emory University, Atlanta, GA, USA.
authors.forename: E R
authors.initials: ER
authors.lastname: Becker
authors.forename: D C
authors.initials: DC
authors.lastname: Morris
authors.forename: S D
authors.initials: SD
authors.lastname: Culler
authors.forename: P D
authors.initials: PD
authors.lastname: Mauldin
authors.forename: L J
authors.initials: LJ
authors.lastname: Shaw
authors.forename: J D
authors.initials: JD
authors.lastname: Talley
authors.forename: W S
authors.initials: WS
authors.lastname: Weintraub
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000191:economics* / Q000628:therapy*; D019317:Evidence-Based Medicine; D005544:Forecasting; D019981:Health Care Sector / Q000639:trends*; D006801:Humans; D008329:Managed Care Programs / Q000458:organization & administration; D013677:Medical Laboratory Science / Q000639:trends; D017410:Practice Guidelines as Topic; D012959:Socioeconomic Factors; D014481:United States
chemical_list: D002317:Cardiovascular Agents